α5-GABAA receptors negatively regulate MYC -amplified medulloblastoma growth
Clicks: 197
ID: 112958
2013
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
197 views
37 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #150 of 438 articles by views in acta neuropathologica
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 438 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Neural tumors often express neurotransmitter receptors as markers of their developmental lineage. Although these receptors have been well characterized in electrophysiological, developmental and pharmacological settings, their importance in the maintenance and progression of brain tumors and, importantly, the effect of their targeting in brain cancers remains obscure. Here, we demonstrate high levels of GABRA5, which encodes the α5-subunit of the GABAA receptor complex, in aggressive MYC-driven, “Group 3” medulloblastomas. We hypothesized that modulation of α5-GABAA receptors alters medulloblastoma cell survival and monitored biological and electrophysiological responses of GABRA5-expressing medulloblastoma cells upon pharmacological targeting of the GABAA receptor. While antagonists, inverse agonists and non-specific positive allosteric modulators had limited effects on medulloblastoma cells, a highly specific and potent α5-GABAA receptor agonist, QHii066, resulted in marked membrane depolarization and a significant decrease in cell survival. This effect was GABRA5 dependent and mediated through the induction of apoptosis as well as accumulation of cells in S and G2 phases of the cell cycle. Chemical genomic profiling of QHii066-treated medulloblastoma cells confirmed inhibition of MYC-related transcriptional activity and revealed an enrichment of HOXA5 target gene expression. siRNA-mediated knockdown of HOXA5 markedly blunted the response of medulloblastoma cells to QHii066. Furthermore, QHii066 sensitized GABRA5 positive medulloblastoma cells to radiation and chemotherapy consistent with the role of HOXA5 in directly regulating p53 expression and inducing apoptosis. Thus, our results provide novel insights into the synthetic lethal nature of α5-GABAA receptor activation in MYC-driven/Group 3 medulloblastomas and propose its targeting as a novel strategy for the management of this highly aggressive tumor.
| Reference Key |
sengupta2013actaα5-gabaa
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Soma Sengupta;Shyamal Dilhan Weeraratne;Hongyu Sun;Jillian Phallen;Sundari K. Rallapalli;Natalia Teider;Bela Kosaras;Vladimir Amani;Jessica Pierre-Francois;Yujie Tang;Brian Nguyen;Furong Yu;Simone Schubert;Brianna Balansay;Dimitris Mathios;Mirna Lechpammer;Tenley C. Archer;Phuoc Tran;Richard J. Reimer;James M. Cook;Michael Lim;Frances E. Jensen;Scott L. Pomeroy;Yoon-Jae Cho;Soma Sengupta;Shyamal Dilhan Weeraratne;Hongyu Sun;Jillian Phallen;Sundari K. Rallapalli;Natalia Teider;Bela Kosaras;Vladimir Amani;Jessica Pierre-Francois;Yujie Tang;Brian Nguyen;Furong Yu;Simone Schubert;Brianna Balansay;Dimitris Mathios;Mirna Lechpammer;Tenley C. Archer;Phuoc Tran;Richard J. Reimer;James M. Cook;Michael Lim;Frances E. Jensen;Scott L. Pomeroy;Yoon-Jae Cho; |
| Journal | acta neuropathologica |
| Year | 2013 |
| DOI |
doi:10.1007/s00401-013-1205-7
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.